Aureka Biotechnologies raises 100 million dollars in Series B funding
Aureka Biotechnologies secured 100 million US dollars in Series B financing to scale biological foundation model training and enhance drug discovery infrastructure
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.